盈利惊喜预测

搜索文档
Sempra (SRE) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2025-07-31 23:07
Sempra (SRE) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on August 7, might help the stock move higher if these key numbers are better than expectations. On ...
Airbnb, Inc. (ABNB) Reports Next Week: Wall Street Expects Earnings Growth
ZACKS· 2025-07-30 23:07
Wall Street expects a year-over-year increase in earnings on higher revenues when Airbnb, Inc. (ABNB) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 6, might help the stock move higher if these key numbers are better than expectation ...
BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth
ZACKS· 2025-07-28 23:06
公司业绩预期 - BioCryst Pharmaceuticals预计在2025年第二季度实现营收1.4885亿美元,同比增长36.2%,每股收益0.03美元,同比增幅达150% [3] - 公司将于8月4日发布财报,实际业绩与预期的差异可能影响股价短期走势 [1][2] - 过去30天共识EPS预期维持不变,但分析师个体调整方向可能未在整体数据中体现 [4] 盈利预测模型分析 - Zacks Earnings ESP模型显示公司Most Accurate Estimate低于共识预期,ESP为-66.67%,结合Zacks Rank 3评级,预示业绩超预期概率较低 [11] - 该模型对正向ESP预测效力显著,当与Zacks Rank 1-3级组合时,业绩超预期概率近70% [8][9] - 公司上季度实现盈亏平衡(预期亏损0.07美元/股),创100%正意外,近四季两次超预期 [12][13] 行业对比 - 同业公司Indivior PLC预计第二季度每股收益0.26美元(同比降40.9%),营收2.4427亿美元(同比降18.3%) [17][18] - Indivior的ESP达+11.54%且Zacks Rank 3,近四季三次超预期,业绩超共识概率较高 [18][19] 业绩影响要素 - 股价变动不仅取决于业绩是否超预期,还受管理层电话会讨论及其他突发因素影响 [2][14] - 公司当前数据未显示强烈盈利惊喜信号,但建议投资者综合考量其他因素 [16]
Earnings Preview: Castle Biosciences, Inc. (CSTL) Q2 Earnings Expected to Decline
ZACKS· 2025-07-28 23:06
Wall Street expects a year-over-year decline in earnings on lower revenues when Castle Biosciences, Inc. (CSTL) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 4, might help the stock move higher if these key numbers are better than e ...